The Beauty Health Company Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for The Beauty Health Company (SKIN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-29.10-100.1244.22-375.11-29.18
Depreciation & Amortization33.6834.6827.1025.3414.50
Deferred Income Tax-3.75-1.08-1.79-3.760.00
Stock Based Compensation26.7022.5428.5012.420.36
Change in Working Capital-27.3923.36-141.91-16.49-2.58
Change in Accounts Receivable20.8016.52-32.03-31.013.70
Change in Inventory-10.50-22.62-84.36-7.29-3.21
Change in Accounts Payable-43.7817.07-2.9510.524.89
Change in Other Working Capital6.0811.30-25.9325.45-0.39
Other Operating Activities16.0011.30-32.70340.421.78
Net Cash from Operating Activities16.1321.75-106.60-28.36-12.44
Investing Activities
Capital Expenditures-6.79-13.0517.3915.62-3.50
Acquisitions0.000.000.00-22.900.00
Sales/Maturities of Investments0.00-9.22-1.48-4.42-0.32
Other Investing Activities0.00-18.46-1.480.780.00
Net Cash from Investing Activities-6.79-31.51-18.87-37.73-3.82
Financing Activities
Debt Repayment-156.080.000.00-251.83-16.77
Common Stock Issued0.000.00-160.00188.380.00
Common Stock Repurchased-1.96-32.40-200.930.00-0.15
Other Financing Activities-0.30-5.05-45.24267.48-1.30
Net Cash from Financing Activities-158.34-37.45-205.24959.0418.27
Summary
Effect of Forex Changes on Cash-3.962.03-2.98-0.540.00
Net Change in Cash-152.96-47.21-330.71892.942.18
Cash at Beginning of Period523.03568.20901.899.490.00
Cash at End of Period370.06523.03568.20901.890.00
Free Cash Flow9.348.70-123.99-43.98-15.94
Supplemental Disclosures
Interest Paid8.019.389.8210.2513.54
Income Taxes Paid2.802.27-1.341.702.43